Halliburton SEC Filings

Halliburton (HAL) insider activity: A company officer (President - Western Hemisphere) reported selling 160,000 shares of common stock on 11/12/2025 at $27.77 per share (transaction code S), pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.

Following the sale, the reporting person beneficially owned 452,373.607 shares. This figure includes 901.551 shares purchased through the Employee Stock Purchase Plan for the period ending March 31, 2025, and 10,193.461 shares accumulated via dividend reinvestment as of September 30, 2025. The filer also lists outstanding stock options, including 43,924 options at a $27.14 exercise price expiring 12/20/2028 and 28,604 options at $34.48 expiring 01/04/2026.

Halliburton (HAL) received a Form 144 notice for a proposed sale of 160,000 common shares. The filing lists an aggregate market value of $4,443,200 for the planned sale, with trades expected around 11/12/2025 on the NYSE. Fidelity Brokerage Services LLC is named as the broker.

As context, 841,626,610 shares were outstanding at the time stated. The seller’s share history includes acquisitions via restricted stock vesting, dividend reinvestment, and ESPP purchases across 2018–2024.

Halliburton Company reported softer Q3 2025 results as industry activity slowed and one-time charges weighed on earnings. Revenue was $5.6 billion, down 2% year over year, with operating income of $356 million versus $871 million a year ago. Net income was $18 million, or $0.02 per share, compared with $571 million, or $0.65 per share, in Q3 2024.

Results reflected $392 million in impairments and other charges, including severance, asset write-offs, and an impairment tied to assets held for sale. The effective tax rate rose to 90.9% due to a $125 million valuation allowance on deferred tax assets, combined with the quarter’s charges. Segment revenue declined 2% in Completion & Production and was relatively flat in Drilling & Evaluation; Europe/Africa/CIS grew 15% while Middle East/Asia fell 8%.

Year-to-date operating cash flow was $1.8 billion, funding $917 million of capex, $757 million of share repurchases (32.9 million shares), and $436 million in dividends. Cash and equivalents were $2.0 billion, and a new $3.5 billion five‑year revolving credit facility was fully available at quarter-end. As of October 17, 2025, 841,626,610 common shares were outstanding.

Halliburton Company furnished an 8‑K announcing it issued a press release with financial results for the quarter ended September 30, 2025, and access details for an investor conference call. The call had been previously announced on September 18, 2025.

The information under Items 2.02 and 7.01, and the press release attached as Exhibit 99.1, is deemed “furnished,” not “filed,” under SEC rules. The press release includes certain non‑GAAP financial measures with reconciliations to the most directly comparable GAAP metrics. The release will also be available on the company’s website.

Halliburton Company filed an 8‑K under Item 8.01 disclosing details of its previously reported minority interest in Voltagrid. The company states its fully diluted ownership in Voltagrid is approximately 20%. This updates prior disclosure by quantifying the stake on a fully diluted basis.

Maurice S. Smith, a Halliburton (HAL) director, reported acquisitions and existing holdings under director compensation plans. The filing shows 1,372.04 stock equivalent units acquired on 09/29/2025 under the Halliburton Directors' Deferred Compensation Plan, with a portion attributable to quarterly dividends and fees based on closing prices of $24.44 on September 24, 2025 and $25.00 on September 29, 2025. The report also lists restricted stock units vesting after one year from grant dates in 12/2024, 12/2023 and 03/2023, and totals of 11,728.754 shares and additional stock equivalent balances of 6,226.77, 5,040.19 and 4,028.23 respectively as reported through September 30, 2025. The units convert one-for-one to common stock and may be settled upon cessation as a director.

Capital Research Global Investors reported beneficial ownership of 87,801,964 shares of Halliburton Co. That stake represents 10.3% of the 852,602,102 shares the filer believes are outstanding. The filing shows CRGI has sole voting power over 87,801,953 shares and sole dispositive power over 87,801,964 shares. The firm states these shares are held in the ordinary course of business and were not acquired to change or influence control of Halliburton. The filing was made on an amendment to Schedule 13G and signed by an authorized officer of Capital Research.

Capital Research Global Investors (CRGI) reports beneficial ownership of 50,061,312 shares of Halliburton common stock, representing 5.8% of the shares believed to be outstanding. CRGI states it has sole voting power over 50,061,245 shares and sole dispositive power over 50,061,312 shares. The filing identifies CRGI as an investment management division of Capital Research and Management Company and affiliated entities that provide investment services under the name Capital Research Global Investors. The statement affirms these shares were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer.